Biocon LimitedNSE: BIOCON

Press Release Dec 14 2022

· Issued by Biocon Limited

Dear Sir/Madam,Please find enclosed the press release titled ���Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India���.The above information will also be available on the website of the Company at www.biocon.com.Kindly take the same on record and acknowledge.

View Attachment